TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/25/22 12:12 | 4/21/22 | PYXS | Pyxis Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chin Mark | MA | H | Former D | S | -5,325 | 3.05 | 0 | -1,746 | -100 | 0 | I | ||||||||||||||
12/17/19 21:23 | 12/13/19 | HARP | Harpoon Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Chin Mark | CA | DT | S.m | -622 | 17.01 | 0 | -37 | -1 | 2,572 | I | |||||||||||||||
12/10/19 20:07 | 12/6/19 | HARP | Harpoon Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Chin Mark | CA | DT | S.m | -5,026 | 17.75 | 0 | -283 | -10 | 2,609 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |